Health Condition 1: - Health Condition 2: O262- Pregnancy care for patient with recurrent pregnancy loss
Conditions
Interventions
None listed
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria for case: 1.Female subjects with 18 to 50 years of age (both inclusive) who are in pre-menopausal status. 2.Documented evidence of atleast one uterine fibroid lesion of 2 cm3 or greater on ultrasonography. 3.Willing to participate in the study. Inclusion criteria for control: 1.Female subjects with 18 to 50 years of age (both inclusive) who are in pre-menopausal status. 2.Documented evidence of no uterine fibroid lesion on ultrasonography. 3.Willing to participate in the study.
Exclusion criteria
Exclusion criteria: Exclusion criteria for both cases and controls: 1.Pregnant and lactating women. 2.Women with a history of abortion or miscarriage in the last 6 months. 3.Women with a history of prior surgery for fibroids (myomectomy) or hysterectomy. 4.Women with concomitant use of vitamin D supplements or history of vitamin D supplement within the last 3 months. 5.Women with concomitant use of hormonal treatment (including oral contraceptives) or history of hormonal treatment within the last 3 months. 6.Women with concomitant use of drug known to increase the serum prolactin levels [e.g., haloperidol, chlorpromazine, thioridazine, thiothixene (typical antipsychotics); risperidone, amisulpride, molindone, zotepine (atypical antipsychotics); sertraline, fluoxetine, paroxetine, pargyline, clorgyline (antidepressants); buspirone, alprazolam (psychotropics); metoclopramide and domperidone (prokinetics), alpha-methyldopa, reserpine and verapamil (antihypertensive), morphine (opiates)]. 7.Women with diabetes mellitus, pituitary, and hypothyroidism, chronic renal failure, or psychiatric disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The association of serum levels of Vitamin D3 and Prolactin will be evaluated in Patients with uterine fibroids and it will compare with healthy individuals.Timepoint: 12 Weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| The association of serum levels of Vitamin D3 and Prolactin will be evaluated with number and size of uterine fibroids.Timepoint: 20 Weeks | — |
Countries
India
Contacts
Public ContactAzaz Ahmad
Indira IVF Hospital Pvt. Ltd.
Outcome results
None listed